Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, featuring promising advancements across various professional medical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA presents a safer, more dependable choice for therap